Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients

por Amir, E, Freedman, OC, Chia, S, Petrella, T, Dent, S, Tonkin, K, Ahmad, I, Rayson, D, Dranitsaris, G, Clemons, M
Publicado 2009

A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarker...

por Freedman, OC, Amir, E, Dranitsaris, G, Dowsett, M, Cole, DEC, Kahn, H, O'Malley, F, Verma, S, Clemons, M
Publicado 2009